Buy Incyte (INCY) on Weakness - BMO Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. AA
10. TECHM:IN

Go back to Buy Incyte (INCY) on Weakness - BMO Capital

Incyte (INCY) IDO Patient Count Worries Are A "Nothing Burger" - Barclays

June 5, 2017 4:13 PM EDT

Barclays maintains Overweight on Incyte (NASDAQ: INCY) price target of $180.00.

Analyst Dr. Geoff Meacham continues to holds INCY scientific and clinical leadership team in high regard and says it is very common to see different numbers of evaluable patients based upon exposure... More